Chemomodulation of sequential high-dose cytarabine by fludarabine in relapsed or refractory acute myeloid leukemia: a randomized trial of the AMLCG-Reference-Cited by-同舟云学术

Chemomodulation of sequential high-dose cytarabine by fludarabine in relapsed or refractory acute myeloid leukemia: a randomized trial of the AMLCG

Published:2013-10-22 Issue:5 Volume:28 Page:1001-1007
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Fiegl M, ,Unterhalt M,Kern W,Braess J,Spiekermann K,Staib P,Grüneisen A,Wörmann B,Schöndube D,Serve H,Reichle A,Hentrich M,Schiel X,Sauerland C,Heinecke A,Rieger C,Beelen D,Berdel W E,Büchner T,Hiddemann W

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2013297.pdf

Reference27 articles.

1. Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 2009; 114: 937–951.

2. Dohner H, Estey EH, Amadori S, Appelbaum FR, Buchner T, Burnett AK et al. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood 2010; 115: 453–474.

3. Ellison RR, Holland JF, Weil M, Jacquillat C, Boiron M, Bernard J et al. Arabinosyl cytosine: a useful agent in the treatment of acute leukemia in adults. Blood 1968; 32: 507–523.

4. Ohno R, Hirano M, Imai K, Koie K, Kamiya T, Nishiwaki H et al. Daunorubicin, cytosine arabinoside, 6-mercaptopurine riboside, and prednisolone (DCMP) combination chemotherapy for acute myelogenous leukemia in adults. Cancer 1975; 36: 1945–1949.

5. Lowenberg B, Ossenkoppele GJ, van Putten W, Schouten HC, Graux C, Ferrant A et al. High-dose daunorubicin in older patients with acute myeloid leukemia. N Engl J Med 2009; 361: 1235–1248.

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world results of venetoclax combined with hypomethylating agents in young adults with relapsed/refractory acute myeloid leukemia;Hematology;2023-10-05

2. Chidamide: Targeting epigenetic regulation in the treatment of hematological malignancy;Hematological Oncology;2022-10-25

3. Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and granulocyte-colony stimulating factor with subsequent bridging to myeloablative allogeneic hematopoietic stem cell transplantation;Mediterranean Journal of Hematology and Infectious Diseases;2022-02-27

4. Humoral Immune Response of SARS-CoV-2–Infected Patients with Cancer: Influencing Factors and Mechanisms;The Oncologist;2021-06-03

5. Dasatinib response in acute myeloid leukemia is correlated with FLT3/ITD, PTPN11 mutations and a unique gene expression signature;Haematologica;2020-05-21